Articles by James Calloway
BP Pauses Share Repurchases Amid $4 Billion Renewables Impairment
BP shares declined over 3% after the energy giant halted its buyback program and recorded significant write-downs in its low-carbon divisions. The company plans to redirect surplus cash toward strengthening its balance sheet and oil and gas investments.
RELX Gains Ahead of Key Earnings, AI Outlook in Focus
RELX shares advanced 1.2% in London trading, recovering from recent AI-related pressure. Investors await full-year results on February 12 for clarity on generative AI's impact.
Barclays Lifts Outlook, Unveils £15 Billion Shareholder Return Plan
Barclays shares advanced after the bank reported a 12% rise in annual profit and outlined a new capital return program exceeding £15 billion through 2028.
BP Suspends Share Repurchases, Prioritizes Debt Reduction After $4.2B Impairments
BP has halted its share buyback program and will redirect excess cash to strengthen its balance sheet after reporting $4.2 billion in impairments and a $3.4 billion quarterly loss under IFRS standards.
NatWest's Wealth Acquisition Shifts Capital Strategy, Shares Stabilize After Selloff
NatWest shares steadied near 621p following a sharp drop after announcing a £2.7 billion Evelyn Partners buy and a £750 million buyback. The deal will reduce its capital ratio and delay further buyback announcements until 2027.
CapitaLand Investment Gains as Ascott Reports Record Signings Ahead of Earnings
CapitaLand Investment shares advanced after its lodging unit Ascott disclosed a record 19,000 units signed in 2025, projecting fee income above S$500 million. Investors await quarterly results for updates on fee growth.
Barclays Sets £15 Billion Shareholder Return Plan Through 2028 on Strong Profits
Barclays has committed to returning at least £15 billion to shareholders between 2026 and 2028, following a 13% rise in 2025 pre-tax profit to £9.1 billion. The bank also raised its financial targets and initiated a new £1 billion share repurchase.
City Developments Nears 52-Week Peak Ahead of Full-Year Earnings Release
Shares of City Developments Ltd advanced 0.6% to S$9.83, approaching a 52-week high as investors await the company's full-year financial results scheduled for February 27.
GSK's RSV Vaccine Advances in China Review, Analysts Adjust Targets
GSK's respiratory syncytial virus vaccine Arexvy has entered regulatory review in China, a key market for adult immunization. The stock declined Monday despite several brokerages raising price targets.
Sembcorp Industries Shares Hold Steady Ahead of FY2025 Earnings, Alinta Acquisition in Focus
Sembcorp Industries shares traded flat at S$6.10 as investors await the company's FY2025 results on February 25. Market attention remains fixed on the pending A$6.5 billion acquisition of Australia's Alinta Energy.
CSE Global Gains Ahead of FY 2025 Earnings Release
CSE Global shares advanced 4.2% to S$1.23, nearing a 52-week high, after the company scheduled its full-year 2025 results announcement for February 26.
ST Engineering Holds Near All-Time High Ahead of Key Earnings Report
ST Engineering shares hover near record levels as investors await full-year results on Feb 27, following a series of product announcements at the Singapore Airshow.